| Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood–Brain Barrier in Non-Human Primates with PET L García-Varela, WM Arif, D Vállez García, T Kakiuchi, H Ohba, N Harada, ... Molecular pharmaceutics 17 (9), 3477-3486, 2020 | 23 | 2020 |
| Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations A Fernández-Ferreiro, J Silva-Rodriguez, FJ Otero-Espinar, ... Investigative Ophthalmology & Visual Science 58 (2), 772-780, 2017 | 22 | 2017 |
| In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET L García-Varela, M Rodríguez-Pérez, A Custodia, R Moraga-Amaro, ... Molecular pharmaceutics 18 (8), 3073-3085, 2021 | 17 | 2021 |
| Preclinical PET study of intravitreal injections A Fernandez-Ferreiro, A Luaces-Rodriguez, P Aguiar, J Pardo-Montero, ... Investigative ophthalmology & visual science 58 (7), 2843-2851, 2017 | 16 | 2017 |
| Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function L García-Varela, D Vállez García, P Aguiar, T Kakiuchi, H Ohba, N Harada, ... European journal of nuclear medicine and molecular imaging 48 (13), 4307-4317, 2021 | 13 | 2021 |
| Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET P Mossel, L Garcia Varela, WM Arif, CWJ van der Weijden, HH Boersma, ... European journal of nuclear medicine and molecular imaging 48 (12), 4105-4106, 2021 | 13 | 2021 |
| Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats J Silva-Rodríguez, L García-Varela, E López-Arias, I Domínguez-Prado, ... Nuclear Medicine and Biology 43 (12), 827-834, 2016 | 12 | 2016 |
| Test–Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function L García-Varela, D Vállez García, M Rodríguez-Pérez, A Van Waarde, ... ACS Chemical Neuroscience 11 (4), 648-658, 2020 | 11 | 2020 |
| Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin M Campaña-Seoane, A Pérez-Gago, G Vázquez, N Conde, P González, ... International Journal of Pharmaceutics 554, 276-283, 2019 | 11 | 2019 |
| Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F] MC225 and PET L Garcia-Varela, P Mossel, P Aguiar, DA Vazquez-Matias, A van Waarde, ... Journal of Controlled Release 347, 500-507, 2022 | 10 | 2022 |
| Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET P Mossel, WM Arif, GS De Souza, LG Varela, CWJ van der Weijden, ... European journal of nuclear medicine and molecular imaging 50 (13), 3917-3927, 2023 | 9 | 2023 |
| Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions S Díez-Villares, L García-Varela, S Groba-de Antas, JR Caeiro, ... Journal of Controlled Release 356, 702-713, 2023 | 8 | 2023 |
| [18F]-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage N Gómez-Lado, E López-Arias, R Iglesias-Rey, L Díaz-Platas, ... Molecular pharmaceutics 17 (12), 4667-4675, 2020 | 7 | 2020 |
| Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum K Prasad, EFJ de Vries, JWA Sijbesma, L Garcia-Varela, ... Molecular pharmaceutics 19 (8), 2992-3001, 2022 | 5 | 2022 |
| Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates L García-Varela, DV García, T Kakiuchi, H Ohba, S Nishiyama, T Tago, ... Molecular pharmaceutics 18 (1), 416-428, 2020 | 5 | 2020 |
| PET imaging of ABC transporters at the blood-brain barrier L García-Varela, P Mossel, M Benadiba, H Savolainen, NA Colabufo, ... PET and SPECT of Neurobiological Systems, 809-850, 2021 | 3 | 2021 |
| Head to head comparison of (R)-[C-11] verapamil and [18F] MC225 in non-human primates; tracers for measuring P-gp function at the blood-brain barrier J Toyohara, L Garcia-Varela, T Kakiuchi, O Hiroyuki, S Nishiyama, T Tago, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 44, S366-S366, 2017 | 3 | 2017 |
| [18F] MC225 PET for the dose-response assessment of tariquidar inhibition of blood-brain barrier P-glycoprotein function in vivo LG Varela, P Mossel, P Aguiar, DV Matias, A van Waarde, A Willemsen, ... European Journal of Nuclear Medicine and Molecular Imaging 48 (Suppl. 1), S106, 2021 | 2 | 2021 |
| Impact of A (2A) R agonist and antagonist on binding of the dopamine D-2 receptor ligand [C-11] raclopride in the rodent striatum K Prasad, EFJ de Vries, JWA Sijbesma, KA Attia, C Kwizera, ... European Journal of Nuclear Medicine and Molecular Imaging 47 (SUPPL 1 …, 2020 | 2 | 2020 |
| Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models L García-Varela, J Codesido, A Perez-Pedrosa, M Muñoz-González, ... International Journal of Pharmaceutics 652, 123795, 2024 | 1 | 2024 |
Pablo Aguiar, PhDCIMUS, Universidade Santiago de Compostela & Nuclear Medicine Dept, Univ. Hospital IDISΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα sergas.es
